Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRBP |
---|---|---|
09:32 ET | 3845 | 20.775 |
09:34 ET | 1500 | 20.485 |
09:36 ET | 13052 | 20.1324 |
09:38 ET | 4118 | 20.36 |
09:39 ET | 753 | 20.3388 |
09:41 ET | 9047 | 19.985 |
09:43 ET | 3426 | 20.11 |
09:45 ET | 851 | 20.0347 |
09:48 ET | 2986 | 20.095 |
09:50 ET | 4550 | 20.3063 |
09:52 ET | 2100 | 20.2393 |
09:54 ET | 811 | 20.28 |
09:56 ET | 11783 | 20.4 |
09:57 ET | 2863 | 20.44 |
09:59 ET | 6690 | 20.43 |
10:01 ET | 1650 | 20.68 |
10:03 ET | 561 | 20.55 |
10:06 ET | 899 | 20.61 |
10:08 ET | 789 | 20.465 |
10:10 ET | 461 | 20.385 |
10:12 ET | 400 | 20.45 |
10:14 ET | 1397 | 20.37 |
10:15 ET | 4763 | 20.3 |
10:17 ET | 3412 | 20.09 |
10:19 ET | 16674 | 19.825 |
10:21 ET | 5890 | 19.89 |
10:24 ET | 19180 | 20.05 |
10:26 ET | 2450 | 20.04 |
10:28 ET | 4475 | 19.85 |
10:30 ET | 39851 | 20.34 |
10:32 ET | 1450 | 20.35 |
10:33 ET | 16012 | 20.4 |
10:35 ET | 10266 | 20.2844 |
10:37 ET | 700 | 20.305 |
10:39 ET | 9187 | 20.54 |
10:42 ET | 30386 | 20.83 |
10:44 ET | 5843 | 20.78 |
10:46 ET | 600 | 20.7 |
10:48 ET | 600 | 20.68 |
10:50 ET | 1970 | 20.46 |
10:51 ET | 3590 | 20.15 |
10:53 ET | 2800 | 20.24 |
10:55 ET | 1000 | 20.125 |
10:57 ET | 1300 | 20.11 |
11:00 ET | 700 | 20.215 |
11:02 ET | 12435 | 20.3162 |
11:04 ET | 200 | 20.33 |
11:06 ET | 11511 | 20.25 |
11:08 ET | 800 | 20.23 |
11:09 ET | 800 | 20.24 |
11:11 ET | 1360 | 20.23 |
11:13 ET | 3125 | 20.14 |
11:15 ET | 2400 | 20.11 |
11:18 ET | 2400 | 20.08 |
11:20 ET | 300 | 20.125 |
11:22 ET | 1000 | 20.125 |
11:24 ET | 4370 | 20.05 |
11:26 ET | 1361 | 19.93 |
11:27 ET | 9047 | 20.03 |
11:29 ET | 11970 | 20.15 |
11:31 ET | 4826 | 20.15 |
11:33 ET | 1700 | 20.135 |
11:36 ET | 4662 | 20.37 |
11:38 ET | 450 | 20.29 |
11:40 ET | 433 | 20.32 |
11:42 ET | 1922 | 20.265 |
11:44 ET | 475 | 20.235 |
11:45 ET | 400 | 20.23 |
11:47 ET | 200 | 20.235 |
11:49 ET | 1756 | 20.24 |
11:51 ET | 828 | 20.225 |
11:54 ET | 200 | 20.225 |
11:56 ET | 617 | 20.245 |
11:58 ET | 4972 | 20.21 |
12:00 ET | 3097 | 20.01 |
12:02 ET | 225 | 20 |
12:03 ET | 2166 | 20.05 |
12:05 ET | 1406 | 20.105 |
12:07 ET | 401 | 20.105 |
12:09 ET | 1879 | 20.11 |
12:12 ET | 828 | 20.11 |
12:14 ET | 900 | 20.17 |
12:16 ET | 400 | 20.11 |
12:18 ET | 1188 | 20.11 |
12:20 ET | 1769 | 20.1201 |
12:21 ET | 228 | 20.15 |
12:25 ET | 2464 | 20.09 |
12:27 ET | 23158 | 20.105 |
12:30 ET | 2605 | 20.1 |
12:32 ET | 5011 | 20.06 |
12:34 ET | 1276 | 20.06 |
12:36 ET | 752 | 20.07 |
12:38 ET | 1883 | 20.1 |
12:39 ET | 12191 | 20.12 |
12:41 ET | 407 | 20.115 |
12:43 ET | 5300 | 20.09 |
12:45 ET | 1934 | 20.125 |
12:48 ET | 1841 | 20.15 |
12:50 ET | 969 | 20.12 |
12:52 ET | 636 | 20.12 |
12:54 ET | 400 | 20.19 |
12:56 ET | 200 | 20.12 |
12:57 ET | 100 | 20.07 |
12:59 ET | 26400 | 20.03 |
01:01 ET | 1547 | 20.22 |
01:03 ET | 5594 | 19.86 |
01:06 ET | 3242 | 19.81 |
01:08 ET | 2181 | 19.79 |
01:10 ET | 3280 | 19.63 |
01:12 ET | 21126 | 19.35 |
01:14 ET | 50731 | 18.995 |
01:15 ET | 29229 | 19.16 |
01:17 ET | 10174 | 19.39 |
01:19 ET | 15010 | 19.2859 |
01:21 ET | 3850 | 19.25 |
01:24 ET | 22261 | 19.03 |
01:26 ET | 350 | 19.06 |
01:28 ET | 100 | 19.06 |
01:30 ET | 2550 | 19.2087 |
01:32 ET | 13556 | 19.255 |
01:33 ET | 3638 | 19.34 |
01:35 ET | 7716 | 19.28 |
01:37 ET | 800 | 19.31 |
01:39 ET | 11629 | 19.25 |
01:42 ET | 2470 | 19.175 |
01:44 ET | 700 | 19.17 |
01:46 ET | 1125 | 19.2611 |
01:48 ET | 3550 | 19.21 |
01:50 ET | 3830 | 19.25 |
01:51 ET | 12017 | 19.4 |
01:53 ET | 5620 | 19.45 |
01:55 ET | 1709 | 19.48 |
01:57 ET | 600 | 19.5 |
02:00 ET | 2513 | 19.4 |
02:02 ET | 2681 | 19.435 |
02:04 ET | 200 | 19.445 |
02:06 ET | 100 | 19.4 |
02:08 ET | 649 | 19.39 |
02:09 ET | 600 | 19.34 |
02:11 ET | 1619 | 19.302 |
02:13 ET | 500 | 19.31 |
02:15 ET | 1108 | 19.3 |
02:18 ET | 400 | 19.28 |
02:20 ET | 2523 | 19.46 |
02:22 ET | 1710 | 19.425 |
02:24 ET | 3311 | 19.5 |
02:26 ET | 3708 | 19.45 |
02:27 ET | 1296 | 19.52 |
02:29 ET | 2414 | 19.36 |
02:31 ET | 4666 | 19.42 |
02:33 ET | 600 | 19.46 |
02:36 ET | 1025 | 19.46 |
02:38 ET | 2324 | 19.5 |
02:40 ET | 3125 | 19.48 |
02:42 ET | 8500 | 19.535 |
02:44 ET | 1000 | 19.55 |
02:45 ET | 8054 | 19.48 |
02:47 ET | 4036 | 19.47 |
02:49 ET | 700 | 19.53 |
02:51 ET | 1594 | 19.465 |
02:54 ET | 300 | 19.5578 |
02:56 ET | 550 | 19.52 |
03:00 ET | 5185 | 19.54 |
03:02 ET | 1374 | 19.52 |
03:03 ET | 1068 | 19.52 |
03:05 ET | 5241 | 19.63 |
03:07 ET | 6837 | 19.58 |
03:09 ET | 300 | 19.63 |
03:12 ET | 1094 | 19.74 |
03:14 ET | 600 | 19.64 |
03:16 ET | 2124 | 19.585 |
03:18 ET | 5051 | 19.48 |
03:20 ET | 950 | 19.46 |
03:21 ET | 1236 | 19.52 |
03:23 ET | 622 | 19.525 |
03:25 ET | 2300 | 19.49 |
03:27 ET | 1600 | 19.64 |
03:30 ET | 1665 | 19.615 |
03:32 ET | 1639 | 19.54 |
03:34 ET | 9991 | 19.75 |
03:36 ET | 3664 | 19.61 |
03:38 ET | 6453 | 19.5 |
03:39 ET | 4404 | 19.46 |
03:41 ET | 5670 | 19.39 |
03:43 ET | 21544 | 19.1828 |
03:45 ET | 4127 | 19.16 |
03:48 ET | 5341 | 19.29 |
03:50 ET | 4658 | 19.27 |
03:52 ET | 6426 | 19.25 |
03:54 ET | 14853 | 19.13 |
03:56 ET | 16414 | 19.23 |
03:57 ET | 9407 | 19.2782 |
03:59 ET | 101382 | 19.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 248.5M | -3.3x | --- |
Black Diamond Therapeutics Inc | 245.8M | -2.7x | --- |
Compass Therapeutics Inc. | 253.2M | -5.3x | --- |
Trevi Therapeutics Inc | 242.5M | -8.0x | --- |
Zura Bio Ltd | 258.9M | -7.8x | --- |
XBiotech Inc | 235.5M | -6.4x | --- |
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $248.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 12.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.53 |
EPS | $-5.82 |
Book Value | $-1.56 |
P/E Ratio | -3.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.